DENTSPLY SIRONA Inc. (XRAY): Price and Financial Metrics


Today's Latest Price: $48.04 USD

0.20 (0.42%)

Updated Jun 4 4:00pm

Add XRAY to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

XRAY Stock Summary

  • DENTSPLY SIRONA Inc's market capitalization of $10,480,808,250 is ahead of 85.92% of US-listed equities.
  • XRAY's current price/earnings ratio is 125.07, which is higher than 95.58% of US stocks with positive earnings.
  • Over the past twelve months, XRAY has reported earnings growth of -119.68%, putting it ahead of just 13.62% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to DENTSPLY SIRONA Inc, a group of peers worth examining would be CINF, Y, ROL, BRO, and WRB.
  • XRAY's SEC filings can be seen here. And to visit DENTSPLY SIRONA Inc's official web site, go to
XRAY Daily Price Range
XRAY 52-Week Price Range

XRAY Stock Price Chart More Charts

XRAY Price/Volume Stats

Current price $48.04 52-week high $60.87
Prev. close $47.84 52-week low $31.58
Day low $47.09 Volume 1,425,228
Day high $48.47 Avg. volume 2,378,571
50-day MA $40.89 Dividend yield 0.84%
200-day MA $50.43 Market Cap 10.52B


DENTSPLY International designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company was founded in 1899 and is based in York, Pennsylvania.

XRAY Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

Below please find a table outlining a discounted cash flow forecast for XRAY, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that DENTSPLY SIRONA Inc ranked in the 30th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 52%. The most interesting components of our discounted cash flow analysis for DENTSPLY SIRONA Inc ended up being:

  • As a business, XRAY is generating more cash flow than 71.42% of positive cash flow stocks in the Healthcare.
  • XRAY's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 36.49% of tickers in our DCF set.
  • DENTSPLY SIRONA Inc's effective tax rate, as measured by taxes paid relative to net income, is at 29 -- greater than 89.89% of US stocks with positive free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of DENTSPLY SIRONA Inc? See CAH, IONS, PRAH, BIO, and ESMC.

XRAY Latest News Stream

Event/TimeNews Detail
Loading, please wait...

XRAY Latest Social Stream

Loading social stream, please wait...

View Full XRAY Social Stream

Latest XRAY News From Around the Web

Below are the latest news stories about DENTSPLY SIRONA Inc that investors may wish to consider to help them evaluate XRAY as an investment opportunity.

Al Gore Sells Credicorp and Adds 3 New Holdings

Former US vice president's firm releases 1st-quarter portfolio Continue reading...

Yahoo | May 27, 2020

Dentsply Sirona to Present at the Stifel 2020 Virtual Jaws and Paws Conference on May 27th

DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (XRAY), the Dental Solutions Company, today announced that it will participate in the Stifel 2020 Jaws and Paws Conference on May 27th. Don Casey, Chief Executive Officer, will represent the company and is scheduled to participate in a fireside chat at 4:45PM Eastern Time. A replay of the presentation will also be available on the Dentsply Sirona website at

Yahoo | May 25, 2020

Dentsply Sirona Inc. -- Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc.

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc. New York, May 21, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Dentsply Sirona Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

Yahoo | May 21, 2020

Dentsply Sirona Declares Quarterly Cash Dividend

CHARLOTTE, N.C., May 21, 2020 -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company™, announced that its Board of Directors declared a.

Yahoo | May 21, 2020

Dentsply Sirona Inc. -- Moody's affirms Dentsply Sirona's ratings; assigns Baa2 to unsecured notes; stable outlook

Moody's Investors Service, ("Moody's") today affirmed Dentsply Sirona Inc.'s Baa2 senior unsecured rating, its Baa2 issuer rating and Prime-2 Commercial Paper rating. Moody's also assigned a Baa2 rating to the company's proposed offering of senior unsecured notes.

Yahoo | May 20, 2020

Read More 'XRAY' Stories Here

XRAY Price Returns

1-mo 19.09%
3-mo 7.71%
6-mo -16.86%
1-year -12.95%
3-year -22.70%
5-year -5.03%
YTD -14.87%
2019 53.14%
2018 -43.00%
2017 14.66%
2016 -4.64%
2015 14.84%

XRAY Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full XRAY Dividend History

Continue Researching XRAY

Want to see what other sources are saying about DENTSPLY SIRONA Inc's financials and stock price? Try the links below:

DENTSPLY SIRONA Inc (XRAY) Stock Price | Nasdaq
DENTSPLY SIRONA Inc (XRAY) Stock Quote, History and News - Yahoo Finance
DENTSPLY SIRONA Inc (XRAY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.4221 seconds.